NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

SEER

Seer Inc

Jul 02 • 04:00PM ET

2.21

Dollar change +0.02
Percentage change 0.91	%

Healthcare • Biotechnology • USA • NASD

Peers: TXG NDAQ GH ILMN TWST QGEN CDNA NEO EXAS PACB

| Held by: VTI VXF PRFZ IWC AVSC DFSU AVUS DXUV DFAS DFAT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.41	Insider Own	45.45%	Shs Outstand	55.39M	Perf Week	8.87%
Market Cap	130.05M	Forward P/E	-	EPS next Y	-0.91	Insider Trans	-0.31%	Shs Float	32.10M	Perf Month	3.27%
Enterprise Value	-84.27M	PEG	-	EPS next Q	-0.37	Inst Own	30.05%	Short Float	5.55%	Perf Quarter	33.13%
Income	-85.87M	P/S	8.52	EPS this Y	13.58%	Inst Trans	-4.82%	Short Ratio	6.10	Perf Half Y	-2.21%
Sales	15.26M	P/B	0.42	EPS next Y	24.64%	ROA	-22.33%	Short Interest	1.78M	Perf YTD	-4.33%
Book/sh	5.23	P/C	0.54	EPS next 5Y	16.10%	ROE	-24.73%	52W High	2.62 -15.81%	Perf Year	31.55%
Cash/sh	4.07	P/FCF	-	EPS past 3/5Y	-5.91% -39.46%	ROIC	-25.71%	52W Low	1.56 41.67%	Perf 3Y	-74.09%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	29.69% 160.62%	Gross Margin	30.11%	Volatility	3.92% 3.97%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-5.52	EPS Y/Y TTM	-8.59%	Oper. Margin	-627.15%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	18.81	Sales Y/Y TTM	-1.02%	Profit Margin	-562.77%	RSI (14)	61.66	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	19.34	EPS Q/Q	-4.87%	SMA20	4.91%	Beta	1.57	Target Price	3.00
Payout	-	Debt/Eq	0.08	Sales Q/Q	37.15%	SMA50	8.14%	Rel Volume	0.51	Prev Close	2.19
Employees	134	LT Debt/Eq	0.07	Earnings	May 13 AMC	SMA200	5.04%	Avg Volume	292.31K	Price	2.21
IPO	Dec 04, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.03% 29.38%	Trades		Volume	148,576	Change	0.91%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Neutral	$10
Jan-04-23	Downgrade	BofA Securities	Neutral → Underperform	$9 → $6.50
Aug-11-22	Downgrade	JP Morgan	Overweight → Neutral	$20 → $12
Oct-15-21	Resumed	Cowen	Outperform
Dec-29-20	Initiated	Morgan Stanley	Equal-Weight	$65
Dec-29-20	Initiated	JP Morgan	Overweight	$75
Dec-29-20	Initiated	Cowen	Outperform
Dec-29-20	Initiated	BofA Securities	Neutral	$69

Jun-10-25 12:00PM	What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now? (Zacks)
Jun-01-25 07:00AM	Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults (GlobeNewswire)
May-29-25 07:00AM	Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency (GlobeNewswire)
May-14-25 08:10AM	Q1 2025 Seer Inc Earnings Call (Thomson Reuters StreetEvents) +9.90%
03:15AM	Seer Inc (SEER) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
05:15PM	Loading…
May-13-25 05:15PM	Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook (GlobeNewswire)
May-12-25 09:44AM	What To Expect From Seer Inc (SEER) Q1 2025 Earnings (GuruFocus.com)
07:25AM	CytomX Therapeutics (CTMX) Beats Q1 Earnings and Revenue Estimates (Zacks)
May-08-25 08:25AM	Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
May-05-25 05:45PM	AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-24-25 04:05PM	Seer to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Mar-25-25 09:35AM	After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) (Zacks)
Mar-24-25 09:35AM	After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) (Zacks)
Mar-06-25 09:35AM	Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround (Zacks)
11:38AM	Loading…
Feb-28-25 11:38AM	Q4 2024 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
02:39AM	Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... (GuruFocus.com)
Feb-27-25 06:40PM	Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook (GlobeNewswire)
Feb-26-25 08:16AM	Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-21-25 07:00AM	Seer to Participate in the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-20-25 07:00AM	Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025 (GlobeNewswire)
Feb-13-25 04:15PM	Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Jan-02-25 04:05PM	Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference (GlobeNewswire) +6.01%
Nov-21-24 04:05PM	Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500 (GlobeNewswire)
Nov-08-24 07:00AM	Seer to Participate in Upcoming November Investor Conferences (GlobeNewswire) +7.21%
Nov-07-24 02:23AM	Seer Inc (SEER) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com) +7.25%
Nov-06-24 06:00PM	Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports Third Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific (GlobeNewswire)
08:07AM	Loading…
Nov-05-24 08:07AM	Earnings To Watch: Seer Inc (SEER) Reports Q3 2024 Result (GuruFocus.com)
Oct-31-24 07:00AM	Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024 (GlobeNewswire)
Oct-21-24 07:00AM	Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024 (GlobeNewswire)
Oct-17-24 04:05PM	Seer to Report Third Quarter 2024 Financial Results on November 6, 2024 (GlobeNewswire)
Oct-09-24 05:59PM	Seer Inc (SEER) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges Amid Strategic ... (GuruFocus.com)
Aug-22-24 04:05PM	Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-14-24 04:05PM	Seer Appoints Nicolas Roelofs to its Board of Directors (GlobeNewswire)
Aug-09-24 07:00AM	Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Aug-08-24 09:56PM	SEER Stock Earnings: Seer Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:20PM	Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Seer Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-18-24 04:03PM	Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
Jun-11-24 11:11AM	Seer Proteograph Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery (GlobeNewswire)
Jun-02-24 10:55AM	Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study (GlobeNewswire)
May-10-24 03:51PM	Seer Inc (SEER) Q1 2024 Earnings: Revenue Declines but Losses Narrow, Meeting Some Analyst ... (GuruFocus.com)
May-09-24 02:38PM	Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.62%
07:11AM	Q1 2024 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
03:49AM	Seer Inc (SEER) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-24 09:57PM	SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:45PM	Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions (GlobeNewswire)
Apr-23-24 04:05PM	Seer to Report First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire) +8.38%
Mar-02-24 08:18AM	Seer, Inc. (NASDAQ:SEER) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 07:23AM	Q4 2023 Seer Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-29-24 06:00PM	Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:39PM	Seer Inc (SEER) Reports Mixed Financial Results for Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook (GlobeNewswire)
Feb-21-24 04:05PM	Seer to Participate in the TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-06-24 08:00AM	Seer Proteograph Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery (GlobeNewswire) +5.99%
Feb-02-24 09:55AM	Here's Why Seer, Inc. (SEER) Could be Great Choice for a Bottom Fisher (Zacks)
Feb-01-24 04:05PM	Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (GlobeNewswire)
Dec-21-23 04:05PM	Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference (GlobeNewswire)
Nov-10-23 09:00AM	Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-08-23 02:34PM	Seer, Inc. (NASDAQ:SEER) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.23%
09:00AM	Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500 (GlobeNewswire)
Nov-07-23 07:25PM	Seer, Inc. (SEER) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:07PM	Seer Inc (SEER) Reports Modest Revenue Growth Amidst Economic Headwinds (GuruFocus.com)
04:05PM	Seer Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-01-23 09:00AM	Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program (GlobeNewswire)
Oct-19-23 04:05PM	Seer to Report Third Quarter 2023 Financial Results on November 7, 2023 (GlobeNewswire)
Sep-28-23 08:10PM	7 Contrarian Stocks to Buy for the High-Stakes Gambler (InvestorPlace)
Sep-08-23 04:05PM	Seer to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-09-23 03:12PM	Why Shares of Seer Are Slumping Wednesday (Motley Fool) -33.69%
Aug-08-23 08:05PM	Seer, Inc. (SEER) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Seer Reports Second Quarter 2023 Financial Results (GlobeNewswire)
08:28AM	We Think Seer (NASDAQ:SEER) Can Afford To Drive Business Growth (Simply Wall St.)
Jul-27-23 04:05PM	Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-13-23 04:05PM	Seer to Report Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire) -7.54%
Jun-07-23 09:00AM	Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center (GlobeNewswire)
Jun-01-23 09:00AM	Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies (GlobeNewswire) +7.07%
May-09-23 06:15PM	Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Seer Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-24-23 08:56AM	Seer (NASDAQ:SEER) investors are sitting on a loss of 57% if they invested a year ago (Simply Wall St.)
Apr-20-23 04:05PM	Seer to Report First Quarter 2023 Financial Results on May 9, 2023 (GlobeNewswire) -5.40%
Mar-29-23 02:00PM	Seers Proteograph Product Suite identifies undiscovered links between protein variants and lung cancer progression (GlobeNewswire)
Mar-28-23 08:23AM	With 54% ownership of the shares, Seer, Inc. (NASDAQ:SEER) is heavily dominated by institutional owners (Simply Wall St.)
Mar-03-23 08:52AM	Q4 2022 Seer Inc Earnings Call (Thomson Reuters StreetEvents) +29.45%
Mar-02-23 05:35PM	Seer, Inc. (SEER) Reports Q4 Loss, Misses Revenue Estimates (Zacks) +7.67%
04:05PM	Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook (GlobeNewswire)
Mar-01-23 06:15AM	Companies Like Seer (NASDAQ:SEER) Are In A Position To Invest In Growth (Simply Wall St.)
Feb-27-23 09:35AM	Down -26.63% in 4 Weeks, Here's Why You Should You Buy the Dip in Seer, Inc. (SEER) (Zacks) +5.11%
Feb-23-23 12:00PM	Seer, Inc. (SEER) Moves to Buy: Rationale Behind the Upgrade (Zacks)
10:00AM	Seer, Inc. (SEER) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-21-23 04:30PM	Seer to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire) -11.26%
Feb-09-23 04:05PM	Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 (GlobeNewswire)
Dec-27-22 04:05PM	Seer to Present at the J.P. Morgan 41st Annual Health Care Conference (GlobeNewswire) -10.27%
Dec-14-22 08:00AM	DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS (PR Newswire)
Dec-12-22 10:00AM	Seers Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist (GlobeNewswire)
Nov-16-22 05:36AM	Analysts Just Made A Major Revision To Their Seer, Inc. (NASDAQ:SEER) Revenue Forecasts (Simply Wall St.) -9.14%

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nishar Dipchand	Director	Jun 13 '25	Sale	2.08	30,253	62,935	49,204	Jun 16 06:32 PM
DIPCHAND NISHAR	Director	Jun 13 '25	Proposed Sale	2.08	30,253	62,932		Jun 13 04:17 PM
Horn David R.	PRESIDENT & CFO	May 20 '25	Sale	2.08	6,760	14,028	443,629	May 22 04:13 PM
Farokhzad Omid	CEO AND CHAIR	May 20 '25	Sale	2.08	33,663	69,854	1,306,060	May 22 04:10 PM
Horn David R.	PRESIDENT & CFO	Feb 04 '25	Sale	2.24	3,550	7,940	476,961	Feb 05 09:23 PM
Farokhzad Omid	CEO AND CHAIR	Feb 04 '25	Sale	2.24	8,068	18,044	1,428,217	Feb 05 09:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SEER

Seer Inc

Upgrade your FINVIZ experience